AfroCentric Investment Corp Ltd 2021 IR
The report outlines the company's financial and operational performance for the fiscal year ended June 30, 2021. Key highlights include a 25.8% revenue growth, a 15.5% increase in operating profit, and the maintenance of its Level 1 B-BBEE status. The company also played a significant role in South Africa's COVID-19 response, administering over 190,000 vaccinations and investing R31 million in the rollout. Additionally, the report highlights strategic acquisitions, such as the DENIS Group and Forrester Pharma, to expand its healthcare value chain.
Company: AfroCentric Investment Corp Ltd
Sector: Financials
Country: South Africa
Year: 2021
Type: IR
Pages: 134
Back to company
AfroCentric Investment Corp Ltd
Integrated Report
The report outlines the company's financial and operational performance for the fiscal year ended June 30, 2021. Key highlights include a 25.8% revenue growth, a 15.5% increase in operating profit, and the maintenance of its Level 1 B-BBEE status. The company also played a significant role in South Africa's COVID-19 response, administering over 190,000 vaccinations and investing R31 million in the rollout. Additionally, the report highlights strategic acquisitions, such as the DENIS Group and Forrester Pharma, to expand its healthcare value chain.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jul 1, 2020 - Jun 30, 2021
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees